Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial
Titel:
Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial
Auteur:
Brose, Marcia S Robinson, Bruce Sherman, Steven I Krajewska, Jolanta Lin, Chia-Chi Vaisman, Fernanda Hoff, Ana O Hitre, Erika Bowles, Daniel W Hernando, Jorge Faoro, Leonardo Banerjee, Kamalika Oliver, Jennifer W Keam, Bhumsuk Capdevila, Jaume